MedTrace Logo

Pituitary Gland Enlargement Was First Diagnosed by Optical Coherence Tomography (OCT)

NCT03087682 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2017-03-22

No results posted yet for this study

Summary

OCT is now an established way to measure the thickness of the Retinal Nerve Fiber Layer (RNFL) in the retina of the eye. The thickness of the RNFL is always a reflection of the number of the RNFs in any particular area of the retina. Each single RNF runs a long course starting from the cell body which is the retinal ganglion cell in the retina and ends in the thalamus of the brain where it relays visual information to other nerve cell in the thalamus. Along this long course RNFs are in close anatomical relationship with the pituitary gland crossing just above this gland about midway along their course. Hence enlargement of this gland can interfere with the RNFs.

Conditions

  • Pituitary Mass
  • Diagnoses Disease

Interventions

DIAGNOSTIC_TEST

Optical Coherence Tomography (OCT)

OCT is used to measure thickness (numbers) of retinal nerve fibres in different areas of the retina

Sponsors & Collaborators

  • Dr. S.S. Michel Clinic

    lead OTHER

Principal Investigators

  • Shawkat S Michel, FRCS Ed · Dr. S.S. Michel Clinic

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-01
Primary Completion
2014-03-15
Completion
2016-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03087682 on ClinicalTrials.gov